US631708A - Oxypurin and process of making same. - Google Patents
Oxypurin and process of making same. Download PDFInfo
- Publication number
- US631708A US631708A US66864698A US1898668646A US631708A US 631708 A US631708 A US 631708A US 66864698 A US66864698 A US 66864698A US 1898668646 A US1898668646 A US 1898668646A US 631708 A US631708 A US 631708A
- Authority
- US
- United States
- Prior art keywords
- xanthin
- chloro
- oxypurin
- preparation
- trichloropurin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 title description 9
- 230000008569 process Effects 0.000 title description 8
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 41
- 238000002360 preparation method Methods 0.000 description 13
- 239000000243 solution Substances 0.000 description 12
- XPTCECRKQRKFLH-UHFFFAOYSA-N 2,6,8-trichloro-7h-purine Chemical compound ClC1=NC(Cl)=C2NC(Cl)=NC2=N1 XPTCECRKQRKFLH-UHFFFAOYSA-N 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 9
- 150000001875 compounds Chemical class 0.000 description 9
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 8
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 8
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 238000010438 heat treatment Methods 0.000 description 7
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 7
- 230000009467 reduction Effects 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- 239000003513 alkali Substances 0.000 description 6
- SURLGNKAQXKNSP-DBLYXWCISA-N chlorin Chemical group C\1=C/2\N/C(=C\C3=N/C(=C\C=4NC(/C=C\5/C=CC/1=N/5)=CC=4)/C=C3)/CC\2 SURLGNKAQXKNSP-DBLYXWCISA-N 0.000 description 6
- -1 chloro-dioxypurin Chemical compound 0.000 description 6
- 230000001476 alcoholic effect Effects 0.000 description 5
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 125000000217 alkyl group Chemical group 0.000 description 4
- 235000011114 ammonium hydroxide Nutrition 0.000 description 4
- 150000003863 ammonium salts Chemical class 0.000 description 4
- 239000003638 chemical reducing agent Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 4
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical class N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 3
- IWZRTQIXVDXLNL-UHFFFAOYSA-N Hydroxyneurosporene Natural products CC(C)=CCCC(C)=CCCC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC=C(C)CCCC(C)(C)O IWZRTQIXVDXLNL-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 229960000583 acetic acid Drugs 0.000 description 3
- IWZRTQIXVDXLNL-PZKADDIDSA-N chloroxanthin Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCCC(C)(C)O IWZRTQIXVDXLNL-PZKADDIDSA-N 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 239000000155 melt Substances 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- GYEHJUFJTSKYIK-UHFFFAOYSA-N 6-chloro-2,8-diethoxy-7H-purine Chemical compound ClC1=C2NC(=NC2=NC(=N1)OCC)OCC GYEHJUFJTSKYIK-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 150000001447 alkali salts Chemical class 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- 230000011987 methylation Effects 0.000 description 2
- 238000007069 methylation reaction Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- LSMAIBOZUPTNBR-UHFFFAOYSA-N phosphanium;iodide Chemical compound [PH4+].[I-] LSMAIBOZUPTNBR-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- FOPUTWWRUGWKCZ-UHFFFAOYSA-N 2,6,8-trichloro-1-methylpurine Chemical class ClC=1N(C(=C2N=C(N=C2N=1)Cl)Cl)C FOPUTWWRUGWKCZ-UHFFFAOYSA-N 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 238000001321 HNCO Methods 0.000 description 1
- OWIKHYCFFJSOEH-UHFFFAOYSA-N Isocyanic acid Chemical compound N=C=O OWIKHYCFFJSOEH-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 229910001864 baryta Inorganic materials 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- LJYRLGOJYKPILZ-UHFFFAOYSA-N murexide Chemical compound [NH4+].N1C(=O)NC(=O)C(N=C2C(NC(=O)NC2=O)=O)=C1[O-] LJYRLGOJYKPILZ-UHFFFAOYSA-N 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 235000011118 potassium hydroxide Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- RBWSWDPRDBEWCR-RKJRWTFHSA-N sodium;(2r)-2-[(2r)-3,4-dihydroxy-5-oxo-2h-furan-2-yl]-2-hydroxyethanolate Chemical compound [Na+].[O-]C[C@@H](O)[C@H]1OC(=O)C(O)=C1O RBWSWDPRDBEWCR-RKJRWTFHSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- OBSZRRSYVTXPNB-UHFFFAOYSA-N tetraphosphorus Chemical compound P12P3P1P32 OBSZRRSYVTXPNB-UHFFFAOYSA-N 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/36—Sulfur atom
- C07D473/38—Sulfur atom attached in position 6
Definitions
- the present invention relates to the preparation of oxypurins and their alkyl derivatives, and particularly to the production of a series of bodies starting from trichloropurin,a compound which is described in Letters Patent of the United States No. 598,502, dated February 8, 1898.
- the present invention has for its specific object the preparation of xanthin, synthetically, from trichloropurin and also the production of the intermediate new com pound -8- chlorodiakyl-oxypurin.
- This compound is a strong acid and forms stable alkali salts, the formation of the salts resulting in such a modification in the affinities of the three chlorin atoms that on heating With alkali the chlorin atom in the position 6 instead of the chlorin atom in the position 8 is first split off and replaced by oxygen.
- N O. O. (1 H ocl all l ool l N-G-N 2. Preparation of 2-8-dz'chl0ro-6-mc25howg purin.lf in the place of the ethyl-alcoholic solution a methyl-acoholic solution of sodium is employed, the other ingredients and conditions of the above process remaining the same, I obtain 2-S-dichloro-6-methoxy-purin; which melts and decomposes at about 225- centigrade, and which is considerably less soluble in benzene than the ethoxy'compound. l
- This new body has the formula C,l-I,,N ,OlO or, structurally expressed N: C. O. 0 H
- diethoxy compound may also be obtained from the mono-ethoxy-chloro compound by heating the same with excess of sodiu m-ethylate under substantially the same conditions set forth under example 5.
- This diet-hoxypurin however, already undergoes a further conversion into 2-6-dioxypurin or xanthin in the course of the same reaction, the ethyl radicals being split off by the. strong acid, particularly When dealing with large quantities.
- This second phase of the reaction is, however, only partial at ordinary temperatures, and consequently only a proportionately small quantity of hydriodate of xanthin is thrown out. If, on the other hand, the whole is subsequently heated on the water-bath, the conversion into xanthin becomes complete and its hydriodate is precipitated in the form of a thick crystalline mass. From this mass the hydriodic acid is evaporated and the residue is treated with dilute aqueous ammonia in slight excess and filtered.
- IIN O 0 O C NH I coi l HN O N It dissolves with difficulty in hot water and alcohol and glacial acetic acid. From the warm solution of its salts it is precipitated by mineral acids as a colorless granular crystal line mass. On heating it chars without melting. It dissolves readily in concentrated sulfuric acid, being precipitated from such solution by the addition of water. Its alkali salts are readily soluble in water. Its potas sium salt crystallizes from strong potash-lye in the form of very fine pliable needles. Its ammonium salt is much less soluble. On slowly cooling of an aqueous solution of the same it crystallizes in small, but well-developed, apparently rectangular tablets.
- Ohloro-Xanthin like xanthin, gives a very strong murexide test.
- This chloro-dioxypurin is like the chloro-dioxypurin having alkyl combined with the oxygen, such as S-chloro- 2- 6-diethoxypurin, readily converted into Xanthin by the action of a reducing agent, such-as hydrogen-iodid, under substantially the conditions set forth under 5.
- the chloroxanthin may, as set forth in my application Serial No. 668,645, be converted into chlorocafi'ein by methylation and the latter by reduction into catfein or 1-3-7t1imethyl-Xant-hin.
- This mode of obtaining an alkylized Xanthin by methylation and subsequent reduction of, a chloro-oxypurin is, however, claimed generically and specifically in my applications Serial Nos. 668,644 and 668,645, filed concurrently herewith, and is herein only referred to as another illustration of the utility of my compound 8-chloro-2-6- diethoxy-purin.
- the present application is designed to cover the preparation of xanthin by the reduction of a chloro-dioxypurin either with or without alkyl groups combined with the oxygen atoms. More specifically my present application covers the 8-chl0ro-2-fi-diethoxy-purin and its mode of preparation, as also the preparation of Xanthin therefrom by reduction.
- S-chloro- 2-6-diethoxypurin having the formula above given which trickles at about 190, centigrade, and melts at about 205, centigrade, the fusion being attended by decomposition, which is soluble in hot alcohol, in alkalies, but soluble with difficulty in hot water and benzene and which crystallizes in fine needles.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
UNITED STATES PATENT OFFICE,
EMIL FISCHER, OF BERLIN, GERMANY, ASSIGNOR T0 0. F. BOEHRINGER & SOEHNE, OF WALDHOF, GERMANY.
OXYPURIN AND PROCESS OF MAKING SAME.
SPECIFICATION forming part of Letters Patent No. 631 ,708, dated August 22, 1899. Application filed a y 31,1898. Serial N0. 668.646. (Specimens) To all whom it may concern:
Be it known that I, EMIL FISCHER, a citizen of the Empire of Germany, residing at Berlin, in the Empire of Germany, have invented certain new and useful Improvements in the Manufacture of Oxypnrins and their Derivatives; and I do hereby declare the following to be a full, clear, and exact description of the invention, such as will enable others skilled in the art to which it appertains to make and use the same.
The present invention relates to the preparation of oxypurins and their alkyl derivatives, and particularly to the production of a series of bodies starting from trichloropurin,a compound which is described in Letters Patent of the United States No. 598,502, dated February 8, 1898.
The present invention has for its specific object the preparation of xanthin, synthetically, from trichloropurin and also the production of the intermediate new com pound -8- chlorodiakyl-oxypurin.
Before proceeding with the description it should be stated that the nomenclature herein followed is that adopted by the article'published in Beriohte dc'r Dcutschcn O'hcm-ischen Gesellschaft, Vol. 30, page 549. According to this nomenclature a large number of bodies such as caifein, uric acid, guanin, adenin, &c.are designated by the generic term purins, and their nucleus, the purin group,
has its several carbon and nitrogen atoms numbered in the following manner:
Bearing this nomenclature and system of numbering the position of the atoms in the molecule in mind, the use of terms in the following description willbe readily understood. Thus, for example, the compound xanthin, which may be obtained synthetically by the application of my invention, is styled 2-6- oxy-purin under the new nomenclature,since it has the structural formula:
HNCO
occ r-NH 01; HNGN The two known methyl-trichloropurins described in Bem'chte der Deutschen Chemischen Gesellschaft, Vol. 17, page 331, and Vol. 28, page 2488, have hitherto not been susceptible of conversion into Xanthin derivatives by theaction of alkali, for the reason that the latter causes the chlorin atom in the position 8 to be split off. I have found, however, that the unmethylated trichloropurin, the trichloropurin proper,which, together withits method of preparatiomforms the subject-matter of my Letters Patent of the United States No. 598,502, dated February 8, 1898, behaves. in a radically different manner. This compound is a strong acid and forms stable alkali salts, the formation of the salts resulting in such a modification in the affinities of the three chlorin atoms that on heating With alkali the chlorin atom in the position 6 instead of the chlorin atom in the position 8 is first split off and replaced by oxygen.
At ordinary temperature-For example, when acting upon trichloropnrin with alcoholic alkali at ordinary room temperaturethe former is converted into 6-ethoxy-2-8-dichloropurin having the formula:
GIG O-NH 0 11 .00 O-\TI-I The latter body on treatment with hydrochloric acid loses the two ethyl'groups, forming 2-6-dioXy-8-chl0ropurin, having the structural formula:
0.0 GNH ooi lll/ This latter body, which on account of its structure I term chloro-Xanthin, is by reduction converted into 2-6-dioXy-purin oo CNH II o nN-o-N alcohol methyl-alcohol be substituted for the alcoholic solution, S-chloro-2-6-dimethoxypurin will result. My invention, hence, involves the manufacture of chloro-dialkyl-oxypurins generally and of xanthin therefrom,'directly or indirectly.
In the following detailed description I will first describe the preparation of 8-chloro-2-6- diethoxy-purin by proceeding either from the dichloro-alkyl-oxypurin or from trichloropurim and then the preparation of the xanthin from a chloro-dioxypurin without or with alkyl groups bound to the oxygens in the positions 2 and 6. This description will be preceded by the disclosure of the preparation of dichloro-alkyl-oxypurin, 2-8-dichloro-6-ethoxypurin. The proportions given are all understood to be by weight.
1. Preparation of Q-S-dichZoro-G-ethoxy-purim-Four parts dry trichloropurin, whose properties and mode of preparation are set forth in my aforesaid Patent No. 598,502,
dated February 8, 1898, are dissolved in size teen parts of alcohol, and this solution after being rapidly cooled to about 10 to 15 centigrade, and which as a rule has a tendency to throw out crystals of the trichloropurin, is added to a solution of one and two-tenths parts of sodium in twenty-four parts of alcohol cooled to room temperature. A clear pale yellow liquid results, whose temperature rises spontaneously to about 30 centigrade and soon becomes turbid by reason of a precipitation of sodium-chlorid. The mixture is allowed to stand at ordinary temperature for three hours, whereupon fifty parts of water are added and. the whole is supersaturated slightly with acetic acid. The alcohol is then evaporated off, whereby the dichloro-ethoxypurin is precipitated in colorless very flexible acicular crystals. The same is then purified by recrystallization from hot benzol. Its formula is O H Ol N O, or
N: O. O. (1 H ocl all l ool l N-G-N 2. Preparation of 2-8-dz'chl0ro-6-mc25howg purin.lf in the place of the ethyl-alcoholic solution a methyl-acoholic solution of sodium is employed, the other ingredients and conditions of the above process remaining the same, I obtain 2-S-dichloro-6-methoxy-purin; which melts and decomposes at about 225- centigrade, and which is considerably less soluble in benzene than the ethoxy'compound. l
The generic formula for both of the oxyalkyl-dichloro-purins is:
3. Preparation of 2-6-dielfhosry-S-chloropw Tin from t'r'ichloropm'ma -I heat triohloropu+ rin (one part) together with a concentrated alcoholic solution of, sodium-ethylate (con taining one part of sodium) in a closed vesscl to centigrade, maintaining this temperature for three hours. The sodium-ethylate must be in excess or at least t wo molecules more than sufficient to neutralize the trichloropurin is obtained as a copious precipitate,
which forms fine needles. This new body has the formula C,l-I,,N ,OlO or, structurally expressed N: C. O. 0 H
O H .OC CNI-I l OCI l l 'NCN The reactiontakes place according to the equation:
N:G.Ol
It is very similar in behavior to the monoethoxy compound described under example 1. Like the latter, it softens at about 190 centigrade and melts at about 205, the melting-point being not sharply defined, and fusion being attended by decomposition and evolution of gas. In hot acohol it is very readily soluble, but very diificult of solution in benzol. It is readily soluble in alkalies, including ammonia and baryta-water. Boiling water dissolves the same only with difficulty, one thousand parts of the same being required for the solution of one part of the compound.
4. Preparation of 2-6-dieth0my-8-chloroplarin from 2-8-dichloro-d-ethowy-pzwi-n.The diethoxy compound may also be obtained from the mono-ethoxy-chloro compound by heating the same with excess of sodiu m-ethylate under substantially the same conditions set forth under example 5.
5. Conversion of 8-chlo1'o- -6-dieth000y-pu- 'r'in into xcmthim-The chloro-diethoxy-purin may be converted into xanthin under the infiuence of reducing agents. Thus if the same is dissolved in ten times its weight of hydrogen-iodid or hydriodic acid of the specific gravity 1.96 at ordinary temperature the reduction begins promptly, iodin being liberated. The latter is again reduced by the addition of sufficient phosphonium-iodid or yellow phosphorus. The reduction is completed at the end of about an hour at ordinary temperature. In the course of this reaction the intermediate product 2-6-diethoxypurin is most probably formed, but remains dissolved in the hydrogen-iodid. This diet-hoxypurin, however, already undergoes a further conversion into 2-6-dioxypurin or xanthin in the course of the same reaction, the ethyl radicals being split off by the. strong acid, particularly When dealing with large quantities. This second phase of the reaction is, however, only partial at ordinary temperatures, and consequently only a proportionately small quantity of hydriodate of xanthin is thrown out. If, on the other hand, the whole is subsequently heated on the water-bath, the conversion into xanthin becomes complete and its hydriodate is precipitated in the form of a thick crystalline mass. From this mass the hydriodic acid is evaporated and the residue is treated with dilute aqueous ammonia in slight excess and filtered. The residue is then dissolved in a large quantity of warm aqueous ammonia solution for purification. On boiling or evaporating the ammonia the Xanthin is thrown out in the form of a colorless crystalline powder. The product thus obtained synthetically has all of the properties observed for natural xanthin. The reaction whereby the xanthin is formed under this head takes place according to the equations:
6. Conversion of 8-chlor0- -d-cliethoccypu- Tin into chZ0r0-0ccmthin.lt instead of acting upon the chloro-diethoxypurin with a reduc-. ing agent it is submitted to the influence of hydrochloric acid, the chlorin atom remains To completely. purify, the chloro-xanthin is converted into the readily-crystallizing ammonium salt by dissolving in warm very di lute aqueous ammonia. On slowly cooling the ammonium salt is obtained in the form of small, but well-developed, apparently rectangular tablets. The said ammonium salt is then again decomposed by acid, such as hydrochloric acid, as will be readily understood. S-chloro-xanthin has the composition O H OIN O and the molecular structure:
IIN O 0 O C NH I coi l HN O N It dissolves with difficulty in hot water and alcohol and glacial acetic acid. From the warm solution of its salts it is precipitated by mineral acids as a colorless granular crystal line mass. On heating it chars without melting. It dissolves readily in concentrated sulfuric acid, being precipitated from such solution by the addition of water. Its alkali salts are readily soluble in water. Its potas sium salt crystallizes from strong potash-lye in the form of very fine pliable needles. Its ammonium salt is much less soluble. On slowly cooling of an aqueous solution of the same it crystallizes in small, but well-developed, apparently rectangular tablets.
Ohloro-Xanthin, like xanthin, gives a very strong murexide test. This chloro-dioxypurin is like the chloro-dioxypurin having alkyl combined with the oxygen, such as S-chloro- 2- 6-diethoxypurin, readily converted into Xanthin by the action of a reducing agent, such-as hydrogen-iodid, under substantially the conditions set forth under 5.
The chloroxanthin may, as set forth in my application Serial No. 668,645, be converted into chlorocafi'ein by methylation and the latter by reduction into catfein or 1-3-7t1imethyl-Xant-hin. This mode of obtaining an alkylized Xanthin by methylation and subsequent reduction of, a chloro-oxypurin is, however, claimed generically and specifically in my applications Serial Nos. 668,644 and 668,645, filed concurrently herewith, and is herein only referred to as another illustration of the utility of my compound 8-chloro-2-6- diethoxy-purin.
The present application is designed to cover the preparation of xanthin by the reduction of a chloro-dioxypurin either with or without alkyl groups combined with the oxygen atoms. More specifically my present application covers the 8-chl0ro-2-fi-diethoxy-purin and its mode of preparation, as also the preparation of Xanthin therefrom by reduction.
What I claim, and desire to secure by Letters Patent of the United States, is
1. The process which consists in heating trichloropurin having chlorin' in the places (2), (6) and (8) with an alcoholic alkali.
2. The process which consists in heating trichloropurin with excess of sodium-ethylate.
3. The process which consists in heating trichloropurin with a concentrated alcoholic solution of sodium-ethylate in excess, evaporating the alcohol, dissolving the residue in water and supersaturating the solution with acetic acid.
4. As a new chemical compound, S-chloro- 2-6-diethoxypurin, having the formula above given which trickles at about 190, centigrade, and melts at about 205, centigrade, the fusion being attended by decomposition, which is soluble in hot alcohol, in alkalies, but soluble with difficulty in hot water and benzene and which crystallizes in fine needles.
5. The process of preparing Xanthin which consists in acting on S-chloro-dioxy-purin with a reducing agent.
6. The process of preparing xanthin which consists in submitting 8-chloro-2-6-diethoxypurin to the action of a reducing agent.
7. The process of preparing Xanthin which consists in dissolving S-chloro-2-6-diethoxypurin in hydriodic acid at ordinary temperatures then adding phosphonium-iodid to reduce the liberated iodin, then heating the whole on the water-bath, whereby the hydroiodate of Xanthin is precipitated, then evaporating the hydriodic acid and treating the residue with aqueous ammonia in slight excess.
In testimony. whereof I affix my signature in presence of two witnesses.
EMIL FISCHER.
lVitnesses:
CHAS. H. DAY, HENRY HASPER.
ICC
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US66864698A US631708A (en) | 1898-01-31 | 1898-01-31 | Oxypurin and process of making same. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US66864698A US631708A (en) | 1898-01-31 | 1898-01-31 | Oxypurin and process of making same. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US631708A true US631708A (en) | 1899-08-22 |
Family
ID=2700303
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US66864698A Expired - Lifetime US631708A (en) | 1898-01-31 | 1898-01-31 | Oxypurin and process of making same. |
Country Status (1)
| Country | Link |
|---|---|
| US (1) | US631708A (en) |
-
1898
- 1898-01-31 US US66864698A patent/US631708A/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US2484029A (en) | Hydrazine derivatives of pyridazine compounds | |
| US631708A (en) | Oxypurin and process of making same. | |
| US647392A (en) | Oxypurin and process of making same. | |
| US2927112A (en) | 3-amino-6-halopyridazines and process of preparation | |
| US631706A (en) | Oxypurin and process of making same. | |
| US631707A (en) | Xanthin derivatives and process of making same. | |
| US3277092A (en) | 5, 6-substituted dihydro-5-fluoropyrimidines | |
| US1685407A (en) | Dicyclic derivatives of pentamethylene and process for the manufacture of same | |
| US631709A (en) | Oxypurin and process of making same. | |
| US607028A (en) | Emil fischer | |
| US2416617A (en) | Preparation of 2,4-diaminopyrimidines | |
| US3186992A (en) | Derivatives of 4-oxo-6-quinazoline-sulfonamide | |
| US631759A (en) | Alkyl-xanthin and process of making same. | |
| US814496A (en) | Process of making barbituric acids. | |
| US2933498A (en) | 7-aminothiazolo-(5,4-d) pyrimidine | |
| US2670351A (en) | New pyrimidine compounds and proc | |
| US2958692A (en) | S-carboxymethylmercapto-g- | |
| US2673848A (en) | 3-alkenylxanthines and their lower 1-alkyl derivatives | |
| US3098854A (en) | Acid addition salts of basically substituted flavones and preparation thereof | |
| US2667487A (en) | Condensation products of tri | |
| US631705A (en) | Process of making theobromin. | |
| US667388A (en) | Trimethyl-pseudo-uric acid and process of preparing same. | |
| US2654759A (en) | Derivatives of n-hydroxymethyl | |
| US2724710A (en) | 4-pyridazinecarboxylic acid and salts thereof with bases | |
| US569490A (en) | Emil fischer |